Aisling Burnand CBE, 1964-2022

It is with deep sadness that we share the news that our trustee, colleague and friend, Aisling…

Her Majesty Queen Elizabeth II

We at LifeArc are deeply saddened by the passing of our monarch, Her Majesty Queen Elizabeth II.…

Seven questions about LifeArc’s 2030 ambitions

Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.

LifeArc helps create new MRC spin-out company

Our technology transfer team played a crucial role in the formation of Constructive Bio, a new Medical…

Driving translational research into childhood rare diseases

Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases

Advancing novel gene therapies into the clinic

Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.

Study reveals potential new way to treat colorectal cancer

Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.

Startup wins first Advise & Connect Innovation Award

iLOF is a startup that has a novel technology with the potential to transform personalised medicine.

Milner Therapeutics Institute and LifeArc extend strategic partnership

Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics